The Medicines and Healthcare products Regulatory Agency (MHRA) has reappointed three non-executive members to the board after the completion of their terms.
Non-executive directors, Mercy Jeyasingham, Dr Junaid Bajwa, and Rajakumari Long are back on the MHRA board.
They will continue to help MHRA in delivering its goal of utilising scientific expertise, support innovation and the risk-proportionate management of medical products.
MHRA chair Professor Anthony Harnden said, “All three will continue to bring a wealth of knowledge and strategic guidance from across different sectors which will be vital as we continue our work to finalise the Agency’s new organisational strategy in the coming months.”
“I have personally enjoyed working with all three and looking forward to doing so in the future,” he added.
